141 related articles for article (PubMed ID: 16398215)
21. E2F sites in the Op18 promoter are required for high level of expression in the human prostate carcinoma cell line PC-3-M.
Polzin RG; Benlhabib H; Trepel J; Herrera JE
Gene; 2004 Oct; 341():209-18. PubMed ID: 15474303
[TBL] [Abstract][Full Text] [Related]
22. Regulation of transcription of the human MRP7 gene. Characteristics of the basal promoter and identification of tumor-derived transcripts encoding additional 5' end heterogeneity.
Dabrowska M; Sirotnak FM
Gene; 2004 Oct; 341():129-39. PubMed ID: 15474296
[TBL] [Abstract][Full Text] [Related]
23. Efficient transcription of the human angiotensin II type 2 receptor gene requires intronic sequence elements.
Warnecke C; Willich T; Holzmeister J; Bottari SP; Fleck E; Regitz-Zagrosek V
Biochem J; 1999 May; 340 ( Pt 1)(Pt 1):17-24. PubMed ID: 10229654
[TBL] [Abstract][Full Text] [Related]
24. E2F-1 represses transcription of the human telomerase reverse transcriptase gene.
Crowe DL; Nguyen DC; Tsang KJ; Kyo S
Nucleic Acids Res; 2001 Jul; 29(13):2789-94. PubMed ID: 11433024
[TBL] [Abstract][Full Text] [Related]
25. TODRA, a lncRNA at the RAD51 Locus, Is Oppositely Regulated to RAD51, and Enhances RAD51-Dependent DSB (Double Strand Break) Repair.
Gazy I; Zeevi DA; Renbaum P; Zeligson S; Eini L; Bashari D; Smith Y; Lahad A; Goldberg M; Ginsberg D; Levy-Lahad E
PLoS One; 2015; 10(7):e0134120. PubMed ID: 26230935
[TBL] [Abstract][Full Text] [Related]
26. The tumor suppressor gene hypermethylated in cancer 1 is transcriptionally regulated by E2F1.
Jenal M; Trinh E; Britschgi C; Britschgi A; Roh V; Vorburger SA; Tobler A; Leprince D; Fey MF; Helin K; Tschan MP
Mol Cancer Res; 2009 Jun; 7(6):916-22. PubMed ID: 19491197
[TBL] [Abstract][Full Text] [Related]
27. Identification of a large bent DNA domain and binding sites for serum response factor adjacent to the NFI repeat cluster and enhancer region in the major IE94 promoter from simian cytomegalovirus.
Chang YN; Jeang KT; Chiou CJ; Chan YJ; Pizzorno M; Hayward GS
J Virol; 1993 Jan; 67(1):516-29. PubMed ID: 8380090
[TBL] [Abstract][Full Text] [Related]
28. Identification of regulatory regions within the KAI1 promoter: a role for binding of AP1, AP2 and p53.
Marreiros A; Czolij R; Yardley G; Crossley M; Jackson P
Gene; 2003 Jan; 302(1-2):155-64. PubMed ID: 12527206
[TBL] [Abstract][Full Text] [Related]
29. An analysis on transcriptional regulation activity of human XBP1 gene 5' upstream DNA sequences.
Guo FJ; Cheng HE; Yi FP; Peng HM; Song FZ
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2006 Feb; 23(1):1-6. PubMed ID: 16456775
[TBL] [Abstract][Full Text] [Related]
30. CtBP1 transactivates RAD51 and confers cisplatin resistance to breast cancer cells.
Deng Y; Guo W; Xu N; Li F; Li J
Mol Carcinog; 2020 May; 59(5):512-519. PubMed ID: 32124501
[TBL] [Abstract][Full Text] [Related]
31. Sp1 and Sp3 Are important regulators of AP-2gamma gene transcription.
Li M; Kellems RE
Biol Reprod; 2003 Oct; 69(4):1220-30. PubMed ID: 12801994
[TBL] [Abstract][Full Text] [Related]
32. Basal transcription activity of the dyskeratosis congenita gene is mediated by Sp1 and Sp3 and a patient mutation in a Sp1 binding site is associated with decreased promoter activity.
Salowsky R; Heiss NS; Benner A; Wittig R; Poustka A
Gene; 2002 Jun; 293(1-2):9-19. PubMed ID: 12137939
[TBL] [Abstract][Full Text] [Related]
33. MZF1 possesses a repressively regulatory function in ERCC1 expression.
Yan QW; Reed E; Zhong XS; Thornton K; Guo Y; Yu JJ
Biochem Pharmacol; 2006 Mar; 71(6):761-71. PubMed ID: 16426580
[TBL] [Abstract][Full Text] [Related]
34. Cloning and characterization of the promoter region of human focal adhesion kinase gene: nuclear factor kappa B and p53 binding sites.
Golubovskaya V; Kaur A; Cance W
Biochim Biophys Acta; 2004 May; 1678(2-3):111-25. PubMed ID: 15157737
[TBL] [Abstract][Full Text] [Related]
35. Isolation and initial characterization of the BRCA2 promoter.
Davis PL; Miron A; Andersen LM; Iglehart JD; Marks JR
Oncogene; 1999 Oct; 18(44):6000-12. PubMed ID: 10557089
[TBL] [Abstract][Full Text] [Related]
36. Coordinate alterations in the expression of BRCA1, BRCA2, p300, and Rad51 in response to genotoxic and other stresses in human prostate cancer cells.
Yuan R; Fan S; Wang JA; Meng Q; Ma Y; Schreiber D; Goldberg ID; Rosen EM
Prostate; 1999 Jun; 40(1):37-49. PubMed ID: 10344722
[TBL] [Abstract][Full Text] [Related]
37. HSP90 inhibition induces cytotoxicity via down-regulation of Rad51 expression and DNA repair capacity in non-small cell lung cancer cells.
Ko JC; Chen HJ; Huang YC; Tseng SC; Weng SH; Wo TY; Huang YJ; Chiu HC; Tsai MS; Chiou RY; Lin YW
Regul Toxicol Pharmacol; 2012 Dec; 64(3):415-24. PubMed ID: 23069143
[TBL] [Abstract][Full Text] [Related]
38. Multiple DNA elements are required for the growth regulation of the mouse E2F1 promoter.
Hsiao KM; McMahon SL; Farnham PJ
Genes Dev; 1994 Jul; 8(13):1526-37. PubMed ID: 7958837
[TBL] [Abstract][Full Text] [Related]
39. Transcriptional and posttranscriptional down-regulation of the imprinted tumor suppressor gene ARHI (DRAS3) in ovarian cancer.
Lu Z; Luo RZ; Peng H; Rosen DG; Atkinson EN; Warneke C; Huang M; Nishmoto A; Liu J; Liao WS; Yu Y; Bast RC
Clin Cancer Res; 2006 Apr; 12(8):2404-13. PubMed ID: 16638845
[TBL] [Abstract][Full Text] [Related]
40. Regulation of human Cripto-1 gene expression by TGF-beta1 and BMP-4 in embryonal and colon cancer cells.
Mancino M; Strizzi L; Wechselberger C; Watanabe K; Gonzales M; Hamada S; Normanno N; Salomon DS; Bianco C
J Cell Physiol; 2008 Apr; 215(1):192-203. PubMed ID: 17941089
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
